Repligen RGEN Enterprise value

Enterprise value at other companies

Thermo Fisher ScientificTMO

$225.77B+21.7%

DanaherDHR

$158.33B+0.9%

Maravai LifeSciences Holdings, Inc.MRVI

$519.22M+44.6%

Bio-Rad LaboratoriesBIO

$8B+4.2%

Charles River LaboratoriesCRL

$13.73B+38.4%

TEC

Bio-TechneTECH

$8.26B-13.6%

FAQ

What is Repligen's enterprise value?

Repligen (RGEN) reported enterprise value of $7.78B in Q2 2026.

How has Repligen's enterprise value changed year-over-year?

Repligen's enterprise value increased by 22.1% year-over-year, from $6.37B to $7.78B.

What is the long-term trend for Repligen's enterprise value?

Over 5 years (2020 to 2025), Repligen's enterprise value has grown at a -1.2% compound annual growth rate (CAGR), from $9.91B to $9.35B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.